Why women’s chronic pain remains misunderstood—and how technology can change that
Chronic pain affects millions of women, yet it remains one of the most misunderstood and undertreated conditions in modern healthcare. Women are more likely than men to experience chronic pain, but less likely to receive timely diagnoses, effective treatment plans, or sustained clinical support. Too often, pain is minimized, reframed as stress, or treated only after years of escalation.
This gap is not simply about access—it’s about approach. Traditional pain care often focuses on suppressing symptoms rather than understanding the underlying physiological patterns driving pain. For many women, this results in a cycle of medications, side effects, and uncertainty, without addressing what their nervous system is actually experiencing.
Emerging research shows that chronic pain is closely tied to autonomic nervous system dysregulation. When the body remains in a prolonged state of stress or hypervigilance, pain signals can intensify and persist. Treating pain effectively means addressing this root cause, not just the outcome.
MiraWell exists to help close this gap. By using real-time biofeedback and personalized interventions, we aim to give women visibility into their own physiology and tools to actively regulate it. Pain should not be something endured in silence. With the right technology, it can become something understood, managed, and reduced.
We’re partnering with clinicians, researchers, and organizations shaping the future of pain and anxiety care.If you’re interested in clinical deployment, pilots, or product access, we’d love to talk.